广州医药 ›› 2025, Vol. 56 ›› Issue (3): 316-322.DOI: 10.20223/j.cnki.1000-8535.2025.03.004

• 综述 • 上一篇    下一篇

2型糖尿病合并骨质疏松的药物治疗进展

刘静, 李敏, 潘亚雯, 周圆   

  1. 新疆医科大学第六附属医院内分泌科(新疆乌鲁木齐 830002)
  • 收稿日期:2024-07-15 出版日期:2025-03-20 发布日期:2025-04-08
  • 通讯作者: 李敏,E-mail:893819708@qq.com

Advances in the pharmacologic treatment of type 2 diabetes mellitus combined with osteoporosis

LIU Jing, LI Min, PAN Yawen, ZHOU Yuan   

  1. Department of Endocrinology,the Sixth Affiliated Hospital of Xinjiang Medical University,Urumqi 830002,China
  • Received:2024-07-15 Online:2025-03-20 Published:2025-04-08

摘要: 随着糖尿病发病率不断攀升,人们逐渐聚焦于糖尿病合并骨质疏松。围绕此疾病,国内外学者开展了广泛而深入的研究,临床实践聚焦于两点:糖尿病的精准治疗和骨质疏松的有效干预。在确保血糖稳定的基础上,致力于抑制骨吸收、促进骨形成。在此治疗理念指导下,临床医生应当更加全面了解血糖管理与抗骨质疏松药物的作用机制并合理应用,更大程度改善患者的临床症状及预后。然而,药物作用机制复杂,联合应用存在潜在药物相互作用问题。未来研究方向包括探索更安全有效的联合治疗方案,更加精确化地治疗以提高临床疗效。文章分析了降糖药物及抗骨质疏松药物对疾病的疗效,并展望未来的研究方向,旨在为临床实践提供更为深刻与全面的指导。

关键词: 2型糖尿病, 骨质疏松症, 药物治疗

Abstract: As the incidence of diabetes mellitus continues to rise,people are also gradually focusing on diabetes mellitus combined with osteoporosis,which puts patients at a higher risk of fragility fracture.Scholars at home and abroad have conducted extensive and in-depth research around this condition,and clinical practice has focused on two points:first,the precise treatment of diabetes,and second,the effective intervention of osteoporosis.On the basis of ensuring blood glucose stabilization,we are committed to inhibiting bone resorption and promoting bone formation.Under the guidance of this therapeutic concept,we should have a more comprehensive understanding of the mechanism of action of blood glucose management and anti-osteoporosis drugs and apply them rationally,aiming to improve the clinical symptoms and prognosis of patients to a greater extent through dual intervention. However,the mechanism of action of different drugs is complex,and there are potential drug-drug interactions and safety issues associated with their combined use.Future research directions should include exploring safer and more effective combination therapies,developing novel drugs,and more precise and individualized treatments to improve clinical efficacy.This article analyzes the efficacy of glucose-lowering drugs and anti-osteoporosis drugs on the disease and looks forward to future research directions,aiming to provide more profound and comprehensive guidance for clinical practice.

Key words: type 2 diabetes mellitus, osteoporosis, pharmacologic treatment